RCUS Arcus Biosciences, Inc. Stock Quote

RCUS [NYSE]

Index	-	P/E	-	EPS (ttm)	-2.80	Insider Own	20.60%	Shs Outstand	67.08M	Perf Week	-0.64%
Market Cap	1.77B	Forward P/E	-	EPS next Y	-3.80	Insider Trans	63.10%	Shs Float	44.83M	Perf Month	-14.61%
Income	-167.70M	PEG	-	EPS next Q	-0.89	Inst Own	57.40%	Short Float	14.44%	Perf Quarter	-31.71%
Sales	85.20M	P/S	20.73	EPS this Y	-16.00%	Inst Trans	1.19%	Short Ratio	12.14	Perf Half Y	-15.22%
Book/sh	9.91	P/B	2.51	EPS next Y	-16.60%	ROA	-22.40%	Target Price	-	Perf Year	-9.75%
Cash/sh	11.65	P/C	2.14	EPS next 5Y	-	ROE	-31.30%	52W Range	16.69 - 42.36	Perf YTD	-4.12%
Dividend	-	P/FCF	25.38	EPS past 5Y	-	ROI	-24.70%	52W High	-41.24%	Beta	-
Dividend %	-	Quick Ratio	6.40	Sales past 5Y	-	Gross Margin	-	52W Low	49.13%	ATR	1.27
Employees	236	Current Ratio	6.40	Sales Q/Q	427.80%	Oper. Margin	-	RSI (14)	36.96	Volatility	4.45% 4.58%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-72.70%	Profit Margin	-	Rel Volume	0.53	Prev Close	24.88
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	533.14K	Price	24.89
Recom	1.70	SMA20	-2.35%	SMA50	-15.55%	SMA200	-12.08%	Volume	280,159	Change	0.04%

Nov-24-20

Initiated

Berenberg

Buy

$50

Nov-23-20

Initiated

Evercore ISI

Outperform

Apr-03-20

Initiated

Cantor Fitzgerald

Overweight

$21

Mar-04-20

Initiated

Barclays

Overweight

$24

Nov-12-19

Initiated

SunTrust

Buy

$20

Sep-27-19

Initiated

Mizuho

Buy

$22

May-24-19

Resumed

Citigroup

Buy

$25

Oct-09-18

Initiated

Wedbush

Outperform

$22

Apr-09-18

Initiated

Leerink Partners

Outperform

$21

Apr-09-18

Initiated

Goldman

Neutral

$18

Apr-09-18

Initiated

Citigroup

Buy

$18

Jun-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-25-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-19-21 05:05PM	Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting Business Wire -5.19%
May-11-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-05-21 08:15PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates Zacks -5.38%
04:10PM	Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights Business Wire
May-01-21 07:31PM	Top Insider Buys Highlight for the Week of April 30 GuruFocus.com
Apr-26-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-10-21 08:33AM	Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2 Program at the AACR 2021 Annual Meeting Business Wire
Apr-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-03-21 04:10AM	Independent Director Kathryn Falberg Just Bought 12% More Shares In Arcus Biosciences, Inc. (NYSE:RCUS) Simply Wall St.
Mar-24-21 04:15PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire -7.08%
Mar-12-21 12:24PM	Arcus Biosciences, Inc. (RCUS) Stock Jumps 9.5%: Will It Continue to Soar? Zacks -6.56%
Mar-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Mar-04-21 12:13AM	Industry Analysts Just Upgraded Their Arcus Biosciences, Inc. (NYSE:RCUS) Revenue Forecasts By 10% Simply Wall St.
Feb-28-21 02:09AM	Analysts Are Upgrading Arcus Biosciences, Inc. (NYSE:RCUS) After Its Latest Results Simply Wall St.
Feb-25-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Feb-24-21 04:10PM	Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Highlights Business Wire +6.16%
Feb-11-21 04:10PM	Arcus Biosciences to Participate in Upcoming Investor Conferences Business Wire
Feb-10-21 05:27AM	Have Insiders Been Buying Arcus Biosciences, Inc. (NYSE:RCUS) Shares This Year? Simply Wall St.
Feb-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Feb-01-21 04:21PM	Biotech Stock Gritstone Stumbles On Gilead Tie-Up, While Arcus Pops Investor's Business Daily +9.93%
08:13AM	Gilead buys more Arcus Biosciences stock, at a price above the record close MarketWatch
08:00AM	Gilead Sciences to Increase Its Ownership In Arcus Biosciences Business Wire
Jan-26-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire -5.66%
Jan-20-21 01:43PM	Gilead Stock 2021: Why The Biotech Stock Isn't Depending On Covid Drugs Investor's Business Daily +5.15%
Jan-15-21 08:03AM	Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer Business Wire
Jan-14-21 08:36AM	Affimed (AFMD) Catches Eye: Stock Jumps 8.8% Zacks +8.83%
Jan-12-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +5.74%
01:19PM	bluebird (BLUE) to Spin Off Oncology Unit Into Separate Entity Zacks
10:40AM	Moleculin Biotech (MBRX) Jumps: Stock Rises 8.5% Zacks
09:08AM	Zosano Pharma (ZSAN) in Focus: Stock Moves 6.3% Higher Zacks
08:32AM	Exact Sciences (EXAS) Soars: Stock Adds 9.8% in Session Zacks
Jan-11-21 05:03PM	Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium Business Wire
Jan-06-21 04:10PM	Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gileads SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of Directors Business Wire +8.54%
Jan-04-21 08:34AM	Are Options Traders Betting on a Big Move in Arcus Biosciences (RCUS) Stock? Zacks
Dec-10-20 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Dec-09-20 07:30PM	Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer Business Wire
Nov-18-20 04:10PM	Arcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference Business Wire
Nov-12-20 07:22AM	Analysts Just Published A Bright New Outlook For Arcus Biosciences, Inc.'s (NYSE:RCUS) Simply Wall St.
Nov-10-20 05:30PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +5.20%
Nov-05-20 04:10PM	Arcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate Updates Business Wire
Oct-29-20 06:59AM	Arcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcuss Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLC Business Wire +14.24%
Oct-20-20 01:20PM	Arcus Biosciences (NYSE:RCUS) Shareholders Have Enjoyed An Impressive 119% Share Price Gain Simply Wall St.
Oct-08-20 05:00PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Oct-01-20 04:41PM	Jennifer Jarrett Returns to Arcus Biosciences as Chief Operating Officer Business Wire
Sep-28-20 02:43PM	Hedge Funds Keep Buying Arcus Biosciences, Inc. (RCUS) Insider Monkey
Sep-10-20 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +5.01%
Aug-27-20 04:10PM	Arcus Biosciences to Participate in Upcoming September 2020 Investor Conferences Business Wire
Aug-18-20 08:18AM	Gilead announces another cancer deal MarketWatch
Aug-17-20 12:14PM	Trade Alert: The Co-Founder Of Arcus Biosciences, Inc. (NYSE:RCUS), Terry Rosen, Has Just Spent US$999k Buying 1.0% More Shares Simply Wall St.
10:41AM	Weekly CEO Buys Highlight GuruFocus.com
Aug-11-20 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Aug-06-20 04:10PM	Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Business Wire
Aug-04-20 04:10PM	Arcus Biosciences Announces New Employment Inducement Grant Business Wire
Jul-28-20 04:10PM	Arcus Biosciences to Participate in Upcoming August Investor Conferences Business Wire
12:33PM	Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-17-20 10:37AM	Did Hedge Funds Make The Right Call On Arcus Biosciences, Inc. (RCUS) ? Insider Monkey
Jul-13-20 04:05PM	Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Business Wire -7.25%
Jul-09-20 04:15PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jul-07-20 04:10PM	Bob Goeltz to Join Arcus Biosciences as Chief Financial Officer Business Wire +5.37%
Jun-29-20 11:30AM	Has Arcus Biosciences (RCUS) Outpaced Other Medical Stocks This Year? Zacks
Jun-17-20 01:54PM	Hedge Funds Have Never Been This Bullish On Arcus Biosciences, Inc. (RCUS) Insider Monkey
Jun-12-20 11:30AM	Is Arcus Biosciences (RCUS) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-09-20 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jun-03-20 04:20PM	Why Gilead's Coronavirus Drug Could Be A Mega Blockbuster: Analyst Investor's Business Daily -9.62%
04:10PM	Arcus Biosciences to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference Webcast Business Wire
02:27PM	Coronavirus update: Global death toll tops 380,000 as Brazil records biggest one-day increase since start of outbreak MarketWatch
01:20PM	Gilead Sciences Upgraded on Potential Virus Drug Sales TheStreet.com
08:23AM	Gilead's stock upgraded on high hopes for remdesivir revenue MarketWatch
Jun-02-20 08:33AM	Arcus Biosciences (RCUS) Catches Eye: Stock Jumps 5.4% Zacks
May-29-20 06:47PM	Gilead Continues to Build Cancer Franchise GuruFocus.com +11.13%
02:50PM	Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today Motley Fool
May-28-20 10:37PM	Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock Business Wire
10:55AM	Gilead Inks 10-Year Deal With Arcus for Immuno-oncology Drugs Zacks
May-27-20 04:46PM	Arcus Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock Business Wire -19.35%
04:21PM	Here's Why Arcus Biosciences Is Losing Ground Today Motley Fool
02:55PM	Gilead Sciences Signs $2 Billion Partnership with Arcus Biosciences Motley Fool
08:59AM	Gilead & Arcus Join Forces For 10-Year Cancer Deal, Arcus Down 15% In Pre-Market SmarterAnalyst
07:33AM	Gilead to develop immuno-oncology drugs with Arcus MarketWatch
07:11AM	Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies Business Wire
May-26-20 04:10PM	Arcus Biosciences Appoints David Lacey, M.D., to Its Board of Directors Business Wire -6.26%
May-15-20 09:25AM	Companies Like Arcus Biosciences (NYSE:RCUS) Are In A Position To Invest In Growth Simply Wall St. +10.19%
May-12-20 06:20AM	Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020 GlobeNewswire
May-11-20 04:15PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-05-20 07:25PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:10PM	Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates Business Wire
11:30AM	Is Arcus Biosciences (RCUS) Outperforming Other Medical Stocks This Year? Zacks
Apr-30-20 12:34PM	Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q1 Earnings Expected to Decline Zacks -5.98%
Apr-17-20 11:25AM	Gilead drug produced rapid recovery in coronavirus patients, report says MarketWatch
Apr-16-20 04:39PM	This Small Biotech Rocketed To A Record High On Rumored Gilead Interest Investor's Business Daily +89.35%
04:11PM	In cancer-fighting buying spree, Gilead said to eye East Bay biotech American City Business Journals
04:06PM	Arcus stock jumps on Bloomberg News report that Gilead may take a stake MarketWatch
12:24PM	Cancer Drug Maker Arcus Surges as Street Touts $10 Billion Opportunity With Gilead Bloomberg
12:00PM	What Makes Arcus Biosciences, Inc. (RCUS) a Strong Momentum Stock: Buy Now? Zacks
01:53AM	Arcus Surges 50% In After-Hours Trading On Rumored Gilead Stake SmarterAnalyst
Apr-15-20 06:36PM	Arcus Shares Soar on Report Gilead is Considering Acquiring Stake TheStreet.com -7.21%
04:53PM	Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally Bloomberg
Apr-09-20 04:30PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-03-20 09:46AM	How Arcus Biosciences (RCUS) Stock Stands Out in a Strong Industry Zacks

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company is also developing Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab; and AB680, small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer. It has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; a collaboration with AstraZeneca to evaluate domvanalimab, its investigational anti-TIGIT antibody, in combination with Imfinzi (durvalumab) in a registrational Phase 3 clinical trial in patients with unresectable Stage III non-small cell lung cancer; and license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics to develop anti-CD39 antibody for the treatment of cancer. The company was incorporated in 2015 and is headquartered in Hayward, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jarrett Jennifer	Chief Operating Officer	Jun 04	Sale	24.91	1,044	26,006	119,174	Jun 07 04:47 PM
KANEKO YASUNORI	Director	Apr 23	Buy	31.37	4,133	129,652	7,133	Apr 26 04:16 PM
Grossman William	Chief Medical Officer	Apr 23	Sale	31.37	4,133	129,652	6,717	Apr 26 04:14 PM
FALBERG KATHRYN E	Director	Mar 31	Buy	28.35	20,000	566,996	102,106	Apr 02 11:38 AM
Grossman William	Chief Medical Officer	Mar 16	Sale	35.03	2,127	74,509	10,850	Mar 18 04:37 PM
Jarrett Jennifer	Chief Operating Officer	Mar 16	Sale	35.03	8,661	303,394	116,973	Mar 18 04:36 PM
GILEAD SCIENCES INC	10% Owner	Jan 31	Buy	39.00	5,650,000	220,350,000	13,913,029	Feb 02 04:52 PM
Grossman William	Chief Medical Officer	Dec 16	Sale	31.35	2,117	66,368	6,727	Dec 18 04:51 PM
Goeltz II Robert C.	Chief Financial Officer	Sep 09	Buy	21.57	5,000	107,848	5,000	Sep 09 04:53 PM
ROSEN TERRY J	Chief Executive Officer	Aug 10	Buy	23.38	32,050	749,403	3,231,179	Aug 11 05:13 PM
ROSEN TERRY J	Chief Executive Officer	Aug 07	Buy	21.44	11,655	249,911	3,199,129	Aug 11 05:13 PM
Grossman William	Chief Medical Officer	Jul 31	Buy	19.72	200	3,945	600	Aug 04 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience